Titan Pharmaceuticals Announces Completion of Enrollment in Phase 3 Study of Probuphine for Opioid Dependence November 20, 2014
Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2014 Financial Results November 7, 2014
Titan Pharmaceuticals Announces Enrollment Reaches Halfway Mark in Phase 3 Study of Probuphine for Opioid Dependence September 23, 2014
Titan Pharmaceuticals to Present at Rodman & Renshaw 16th Annual Global Investment Conference September 3, 2014
